GlassScriptPhysician profile
Travis Fortin
NPI 1164001293
$2,583.13
in general payments reported to CMS, 2019-2025
12 companies · $1,192 in 2025
The $1,192 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $155 · 2023: $175 · 2024: $1,061 · 2025: $1,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Travel and Lodging: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.75 |
| Travel and Lodging | $482.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $925.88 | 2025 | Comprehensive Shoulder System, Juggerknotless Soft Anchor, Persona |
| Smith+Nephew, INC. | $357.03 | 2023-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Evos |
| Medtronic, INC. | $230.33 | 2022-2023 | |
| Depuy Synthes Sales INC. | $209.83 | 2024 | Symphony, Tfn-Advance, Na |
| Stryker Corporation | $196.00 | 2023-2025 | Axsos, Pangea, Augment Injectable |
| Globus Medical, INC. | $148.33 | 2024 | Elsa |
| Bioventus LLC | $144.10 | 2024-2025 | Bonescalpel & Sonicone (O.R.), Exogen Ultrasound Bone Healing System |
| Si-Bone, INC. | $130.87 | 2024 | |
| Cerapedics INC. | $99.60 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $83.60 | 2025 | |
| Prime Surgical, LLC | $29.22 | 2025 | |
| Convatec INC. | $28.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Fortin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.